Literature DB >> 29435623

The biological basis for concentrated iliac crest aspirate to enhance core decompression in the treatment of osteonecrosis.

Stuart B Goodman1,2.   

Abstract

Core decompression is a surgical procedure that is capable of salvaging the patient's own natural joint, if the operation is performed in the early stages of osteonecrosis, in which the articular surface has not collapsed. The addition of concentrated cells, aspirated from the iliac crest, to the core tract has been shown to enhance the viability of the femoral head, although large, prospective, randomized, blinded multicentre studies are lacking. The rationale for adding these cells to the core decompression tract is to provide osteoprogenitor and vascular progenitor cells to the area of decompressed dead bone, in order to facilitate tissue regeneration and repair. It has become increasingly evident that vast discrepancies exist in different series in regard to the criteria for patient selection, the surgical technique of core decompression, the methods for harvesting, processing, and injecting the cells, and the methodology for determining success or failure in a specific patient cohort. This paper reviews the salient points relevant to the treatment of osteonecrosis by core decompression with addition of concentrated iliac crest aspirates and poses important questions regarding the future successful application of this technique.

Entities:  

Keywords:  Bone healing; Core decompression; Iliac crest aspirate; Osteogenesis; Osteonecrosis

Mesh:

Year:  2018        PMID: 29435623     DOI: 10.1007/s00264-018-3830-1

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  47 in total

1.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.

Authors:  Ph Hernigou; A Poignard; F Beaujean; H Rouard
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

2.  Use of a centrifugation-based, point-of-care device for production of canine autologous bone marrow and platelet concentrates.

Authors:  Michael S Thoesen; Wendy S Vanden Berg-Foels; Tracy Stokol; Kenneth M Rassnick; May S Jacobson; Sherwin V Kevy; Rory J Todhunter
Journal:  Am J Vet Res       Date:  2006-10       Impact factor: 1.156

3.  Combination treatment of biomechanical support and targeted intra-arterial infusion of peripheral blood stem cells mobilized by granulocyte-colony stimulating factor for the osteonecrosis of the femoral head: a randomized controlled clinical trial.

Authors:  Qiang Mao; Weidong Wang; Taotao Xu; Shanxing Zhang; Luwei Xiao; Di Chen; Hongting Jin; Peijian Tong
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

4.  Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors.

Authors:  G F Muschler; H Nitto; C A Boehm; K A Easley
Journal:  J Orthop Res       Date:  2001-01       Impact factor: 3.494

Review 5.  Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges.

Authors:  Ching-Shwun Lin; Zhong-Cheng Xin; Jican Dai; Tom F Lue
Journal:  Histol Histopathol       Date:  2013-04-16       Impact factor: 2.303

Review 6.  Osteonecrosis repair with bone marrow cell therapies: state of the clinical art.

Authors:  Philippe Hernigou; Charles-Henri Flouzat-Lachaniette; Jerome Delambre; Alexandre Poignard; Jerome Allain; Nathalie Chevallier; Helene Rouard
Journal:  Bone       Date:  2014-07-10       Impact factor: 4.398

Review 7.  Core decompression versus nonoperative management for osteonecrosis of the hip.

Authors:  M A Mont; J J Carbone; A C Fairbank
Journal:  Clin Orthop Relat Res       Date:  1996-03       Impact factor: 4.176

Review 8.  An evidence-based guide to the treatment of osteonecrosis of the femoral head.

Authors:  M Chughtai; N S Piuzzi; A Khlopas; L C Jones; S B Goodman; M A Mont
Journal:  Bone Joint J       Date:  2017-10       Impact factor: 5.082

Review 9.  Adult Mesenchymal Stem Cells: When, Where, and How.

Authors:  Arnold I Caplan
Journal:  Stem Cells Int       Date:  2015-07-26       Impact factor: 5.443

Review 10.  Mesenchymal stem cells migration homing and tracking.

Authors:  Abhishek Sohni; Catherine M Verfaillie
Journal:  Stem Cells Int       Date:  2013-09-30       Impact factor: 5.443

View more
  12 in total

1.  Hip osteonecrosis: stem cells for life or behead and arthroplasty?

Authors:  Philippe Hernigou; Gildasio Daltro; Jacques Hernigou
Journal:  Int Orthop       Date:  2018-06-08       Impact factor: 3.075

2.  Osteogenic ability of rat bone marrow concentrate is at least as efficacious as mesenchymal stem cells in vitro.

Authors:  Yusuke Kohno; Tzuhua Lin; Jukka Pajarinen; Monica Romero-Lopez; Masahiro Maruyama; Jhih-Fong Huang; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2019-02-19       Impact factor: 3.368

3.  Core decompression and bone marrow aspirate concentrate injection for Avascular Necrosis (AVN) of the femoral head: A scoping review.

Authors:  Nishant Pawar; Abhishek Vaish; Raju Vaishya
Journal:  J Clin Orthop Trauma       Date:  2021-11-11

4.  The effects of a functionally-graded scaffold and bone marrow-derived mononuclear cells on steroid-induced femoral head osteonecrosis.

Authors:  Masahiro Maruyama; Akira Nabeshima; Chi-Chun Pan; Anthony W Behn; Timothy Thio; Tzuhua Lin; Jukka Pajarinen; Toshiyuki Kawai; Michiaki Takagi; Stuart B Goodman; Yunzhi Peter Yang
Journal:  Biomaterials       Date:  2018-09-20       Impact factor: 12.479

5.  Stem cell therapy in bilateral osteonecrosis: computer-assisted surgery versus conventional fluoroscopic technique on the contralateral side.

Authors:  Philippe Hernigou; Benjamin Thiebaut; Victor Housset; Claire Bastard; Yasuhiro Homma; Younes Chaib; Charles Henri Flouzat Lachaniette
Journal:  Int Orthop       Date:  2018-04-26       Impact factor: 3.075

6.  Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients.

Authors:  Philippe Hernigou; Arnaud Dubory; Yasuhiro Homma; Isaac Guissou; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Hélène Rouard
Journal:  Int Orthop       Date:  2018-05-09       Impact factor: 3.075

7.  Modified trapdoor procedures using autogenous tricortical iliac graft without preserving the broken cartilage for treatment of osteonecrosis of the femoral head: a prospective cohort study with historical controls.

Authors:  Qi Cheng; Feng-Chao Zhao; Shi-Zhuang Xu; Li Zheng; Xin Zheng
Journal:  J Orthop Surg Res       Date:  2020-05-24       Impact factor: 2.359

8.  Efficacy of various core decompression techniques versus non-operative treatment for osteonecrosis of the femoral head: a systemic review and network meta-analysis of randomized controlled trials.

Authors:  Quanzhe Liu; Wenlai Guo; Rui Li; Jae Hyup Lee
Journal:  BMC Musculoskelet Disord       Date:  2021-11-15       Impact factor: 2.362

9.  Combining autologous bone marrow buffy coat and angioconductive bioceramic rod grafting with advanced core decompression improves short-term outcomes in early avascular necrosis of the femoral head: a prospective, randomized, comparative study.

Authors:  Qingtian Li; Weihong Liao; Guangtao Fu; Junxing Liao; Ruiying Zhang; Mengyuan Li; Yuhui Yang; Yuanchen Ma; Minghao Zheng; Qiujian Zheng
Journal:  Stem Cell Res Ther       Date:  2021-06-19       Impact factor: 6.832

10.  10-year follow-up results of the prospective, double-blinded, randomized, controlled study on autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of the femoral head.

Authors:  Mengyuan Li; Yuanchen Ma; Guangtao Fu; Ruiying Zhang; Qingtian Li; Zhantao Deng; Minghao Zheng; Qiujian Zheng
Journal:  Stem Cell Res Ther       Date:  2020-07-16       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.